134 related articles for article (PubMed ID: 21510011)
1. Dental caries as a side effect of infantile hemangioma treatment with propranolol solution.
Girón-Vallejo O; López-Gutiérrez JC; Fernández-Pineda I; Méndez NA; Ruiz Jiménez JI
Pediatr Dermatol; 2010; 27(6):672-3. PubMed ID: 21510011
[TBL] [Abstract][Full Text] [Related]
2. Response to "Dental caries as a side effect of infantile hemangioma treatment with propranolol solution".
Fleming P; Fitzgerald K; Watson R; Irvine A
Pediatr Dermatol; 2011; 28(5):602; author reply 602. PubMed ID: 21916966
[No Abstract] [Full Text] [Related]
3. Low-dose propranolol for infantile haemangioma.
Tan ST; Itinteang T; Leadbitter P
J Plast Reconstr Aesthet Surg; 2011 Mar; 64(3):292-9. PubMed ID: 20615772
[TBL] [Abstract][Full Text] [Related]
4. [Propranolol in the therapy of infantile hemangioma--fascinating, but not with risk].
Fölster-Holst R
J Dtsch Dermatol Ges; 2010 Mar; 8(3):149-50. PubMed ID: 20406338
[No Abstract] [Full Text] [Related]
5. [Hemangioma can be effectively treated with propranolol. Experiences from twelve cases, with promising results and few side effects].
Rosenkvist CJ; Brudin L; Jörgensen E
Lakartidningen; 2013 May 7-21; 110(19-20):942-5. PubMed ID: 23745499
[No Abstract] [Full Text] [Related]
6. Safety of Oral Propranolol for Infantile Hemangioma.
Droitcourt C; Kerbrat S; Rault C; Botrel MA; Happe A; Garlantezec R; Guillot B; Schleich JM; Oger E; Dupuy A
Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29844139
[TBL] [Abstract][Full Text] [Related]
7. Infantile hemangioma of the upper lip and enamel hypoplasia: Two case reports.
Ochando-Ibernón G; Azaña-Defez JM
Pediatr Dermatol; 2019 Nov; 36(6):899-901. PubMed ID: 31468572
[TBL] [Abstract][Full Text] [Related]
8. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
9. The use of propranolol for complicated infantile hemangiomas.
Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
[TBL] [Abstract][Full Text] [Related]
10. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
[TBL] [Abstract][Full Text] [Related]
11. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.
Kim KH; Choi TH; Choi Y; Park YW; Hong KY; Kim DY; Choe YS; Lee H; Cheon JE; Park JB; Park KD; Kang HJ; Shin HY; Jeong JH
JAMA Dermatol; 2017 Jun; 153(6):529-536. PubMed ID: 28423174
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
15. [Effect of treatment of infant parotid hemangioma with no response to oral propranolol].
Tian Y; Guo XS; Nan J; Wang XL; Shen G
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jan; 53(1):49-51. PubMed ID: 29972964
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
Lie E; Püttgen KB
Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
[TBL] [Abstract][Full Text] [Related]
17. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
Li XY; Wang Y; Jin L; Chen JR
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
[TBL] [Abstract][Full Text] [Related]
18. Oral propranolol (Hemangeol) for infantile hemangioma.
Med Lett Drugs Ther; 2014 Jul; 56(1447):61-2. PubMed ID: 25046418
[No Abstract] [Full Text] [Related]
19. A retrospective study of 2 or 3 mg/kg/day propranolol for infantile hemangioma.
Goto K; Ozeki M; Yasue S; Endo S; Fukao T
Pediatr Int; 2020 Jun; 62(6):751-753. PubMed ID: 32490577
[No Abstract] [Full Text] [Related]
20. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
